Second, Pfizer's forward dividend yield stands at 7.47%. At first glance, the drugmaker's dividend payout ratio of 122.5% ...

Tvardi Therapeutics Inc. research and ratings by Barron's. View TVRD revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.

Pfizer (NYSE:PFE) recently presented groundbreaking findings in cancer research, particularly the first-in-human Phase 1 ...

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss t ...

My dividend income hit a record $959 in April, fueled by BDCs and special dividends. Click here for a detailed analysis.

IO Biotech Inc. research and ratings by Barron's. View IOBT revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.

Real-time index price for KBW Finsec Dividend Yield Index (KDX), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

Pfizer share price rallied 12% hitting ₹5,097.40 on the NSE. After the company posted a solid set of Q4 numbers and declared ...

Pharmaceutical giant Pfizer Inc. PFE has signed a significant licensing agreement with China's 3SBio Inc. for an experimental ...

3SBio will receive an upfront payment of $1.25B and is eligible to receive milestone payments associated with certain development, regulatory and commercial milestones up to $4.8B as well as tiered ...

Pfizer, on the other hand, with its improving growth prospects, rising estimates, cheaper valuation, and higher dividend ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.